F. XIII in perioperative coagulation management

Best Practice and Research: Clinical Anaesthesiology

Volumn 24, Issue 1, 2010, Pages 85-93

  Korte, Wolfgang ^a  

^a Institute for Clinical Chemistry and Haematology   (Switzerland)

Author keywords

cross linking; factor XIII; fibrin monomer; intra operative coagulopathy; unexplained bleeding

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; FIBRINOGEN; PLACEBO; THROMBIN;

ABDOMINAL SURGERY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EARLY INTERVENTION; ELECTIVE SURGERY; FIBRINOGEN BLOOD LEVEL; HEMOPHILIA A; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTHROMBIN TIME; REVIEW; SURGICAL STRESS; THROMBOCYTE COUNT; TREATMENT PLANNING;

ANIMALS; BLOOD COAGULATION DISORDERS; FACTOR XIII; FACTOR XIII DEFICIENCY; HUMANS; PERIOPERATIVE CARE;

EID: 77449145525     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.09.011     Document Type: Review

References (67)

1. Lorand L. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma. Annals of the New York Academy of Sciences 202 (1972) 6-30
2. Duckert F., Jung E., and Shmerling D.H. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombosis et Diathesis Haemorrhagica 5 (1960) 179-186
3. Schroeder V., Meili E., Cung T., et al. Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis 95 (2006) 77-84
4. Nakamura S., Kato A., Sakata Y., and Aoki N. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide. British Journal of Haematology 68 (1988) 313-319
5. Lorand L., Velasco P.T., Rinne J.R., et al. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system. Proceedings of the National Academy of Sciences of the United States of America 85 (1988) 232-236
6. Ariens R.A., Philippou H., Nagaswami C., et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96 (2000) 988-995
7. Loewy A.G. Some thoughts on the state in nature, biosynthetic origin, and function of factor XIII. Annals of the New York Academy of Sciences 202 (1972) 41-58
8. Inbal A., Lubetsky A., Krapp T., et al. Impaired wound healing in factor XIII deficient mice. Thrombosis and Haemostasis 94 (2005) 432-437
9. Siebenlist K.R., Meh D.A., and Mosesson M.W. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 35 (1996) 10448-10453
10. Siebenlist K.R., Meh D.A., and Mosesson M.W. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thrombosis and Haemostasis 86 (2001) 1221-1228
11. Mosesson M.W., Siebenlist K.R., and Meh D.A. The structure and biological features of fibrinogen and fibrin. Annals of the New York Academy of Sciences 936 (2001) 11-30
12. Weisberg L.J., Shiu D.T., Greenberg C.S., et al. Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. The Journal of Clinical Investigation 79 (1987) 649-652
13. Ichinose A., Hendrickson L.E., Fujikawa K., et al. Amino acid sequence of the a subunit of human factor XIII. Biochemistry 25 (1986) 6900-6906
14. Ichinose A., McMullen B.A., Fujikawa K., et al. Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry 25 (1986) 4633-4638
15. Kangsadalampai S., and Board P.G. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92 (1998) 2766-2770
16. Muszbek L., Adany R., and Mikkola H. Novel aspects of blood coagulation factor XIII.I. Structure, distribution, activation, and function. Critical Reviews in Clinical Laboratory Sciences 33 (1996) 357-421
17. Adany R., and Muszbek L. Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus. Histochemistry 91 (1989) 169-174
18. Fear J.D., Jackson P., Gray C., et al. Localisation of factor XIII in human tissues using an immunoperoxidase technique. Journal of Clinical Pathology 37 (1984) 560-563
19. Mosesson M.W. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coagulation & Fibrinolysis 8 (1997) 257-267
20. Casadio R., Polverini E., Mariani P., et al. The structural basis for the regulation of tissue transglutaminase by calcium ions. European journal of Biochemistry/FEBS 262 (1999) 672-679
21. Fox B.A., Yee V.C., Pedersen L.C., et al. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallography. The Journal of Biological Chemistry 274 (1999) 4917-4923
22. Tamaki T., and Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. The Journal of Biological Chemistry 257 (1982) 14767-14772
23. Mosesson M.W., Siebenlist K.R., Hernandez I., et al. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. Journal of Thrombosis And Haemostasis 6 (2008) 1565-1570
24. Fickenscher K., Aab A., and Stuber W. A photometric assay for blood coagulation factor XIII. Thrombosis And Haemostasis 65 (1991) 535-540
25. Wilmer M., Rudin K., Kolde H., et al. Evaluation of a sensitive colorimetric fxiii incorporation assay. effects of fxiii val34leu, plasma fibrinogen concentration and congenital fxiii deficiency. Thrombosis Research 102 (2001) 81-91
26. Dempfle C.E., Harenberg J., Hochreuter K., et al. Microtiter assay for measurement of factor XIII activity in plasma. The Journal of Laboratory and Clinical Medicine 119 (1992) 522-528
27. Nishida Y., Ikematsu S., Fukutake K., et al. A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration. Thrombosis Research 36 (1984) 123-131
28. Ivaskevicius V., Windyga J., Baran B., et al. Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia 13 (2007) 649-657
29. Ivaskevicius V., Seitz R., Kohler H.P., et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thrombosis And Haemostasis 97 (2007) 914-921
30. Fadoo Z., and Saleem A.F. Factor XIII deficiency in children-clinical presentation and outcome. Journal of the College of Physicians and Surgeons--Pakistan 18 (2008) 565-568
31. Schroeder V., Durrer D., Meili E., et al. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss Medical Weekly 137 (2007) 272-278
32. Bhattacharya M., Biswas A., Ahmed R.P., et al. Clinico-hematologic profile of factor XIII-deficient patients. Clinical and Applied Thrombosis/Hemostasis 11 (2005) 475-480
33. Padmanabhan L.D., Mhaskar R., Mhaskar A., et al. Factor XIII deficiency: a rare cause of repeated abortions. Singapore Medical Journal 45 (2004) 186-187
34. Asahina T., Kobayashi T., Takeuchi K., et al. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstetrical & Gynecological Survey 62 (2007) 255-260
35. Egbring R., Kroniger A., and Seitz R. Factor XIII deficiency: pathogenic mechanisms and clinical significance. Seminars in Thrombosis and Hemostasis 22 (1996) 419-425
36. Meili E.O. [Clinical course and management of severe congenital factor XIII deficiency]. Hamostaseologie 22 (2002) 48-52
37. Kitchens C.S., and Newcomb T.F. Factor XIII. Medicine (Baltimore) 58 (1979) 413-429
38. Gerlach R., Raabe A., Zimmermann M., et al. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surgical Neurology 54 (2000) 260-264 discussion 4-5
39. Gerlach R., Tolle F., Raabe A., et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33 (2002) 1618-1623
40. Godje O., Haushofer M., Lamm P., et al. The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg 46 (1998) 263-267
41. Godje O., Gallmeier U., Schelian M., et al. Coagulation Factor XIII Reduces Postoperative Bleeding After Coronary Surgery with Extracorporeal Circulation. Thorac Cardiovasc Surg 54 (2006) 26-33
42. Wettstein P., Haeberli A., Stutz M., et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intra-operative bleeding. Anesthesia and Analgesia 99 (2004) 1564-1569 table of contents
43. Korte W.C., Szadkowski C., Gahler A., et al. Factor XIII substitution in surgical cancer patients at high risk for intra-operative bleeding. Anesthesiology 110 (2009) 239-245
44. Korte W., Hinnen C., Degiacomi P., et al. XIII deficiency in the surgical intensive care unit is more frequent than a relevant fibrinogen deficiency. Haemostaseologie 27 (2007) A61
45. Hoffman M.A. cell-based model of coagulation and the role of factor VIIa. Blood Reviews 17 Suppl. 1 (2003) S1-S5
46. Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. Journal of Thrombosis and Haemostasis 3 (2005) 1337-1348
47. Siebenlist K.R., and Mosesson M.W. Factors affecting gamma-chain multimer formation in cross-linked fibrin. Biochemistry 31 (1992) 936-941
48. Mosesson M.W. Fibrinogen gamma chain functions. Journal of Thrombosis and Haemostasis 1 (2003) 231-238
49. Ichinose A. Physiopathology and regulation of factor XIII. Thrombosis and Haemostasis 86 (2001) 57-65
50. Hornyak T.J., and Shafer J.A. Role of calcium ion in the generation of factor XIII activity. Biochemistry 30 (1991) 6175-6182
51. Brummel K.E., Butenas S., and Mann K.G. An integrated study of fibrinogen during blood coagulation. The Journal of Biological Chemistry 274 (1999) 22862-22870
52. Paye M., Nusgens B., and Lapiere C.M. Factor XIII of blood coagulation decreases the susceptibility of collagen precursors to proteolysis. Biochim Biophys Acta 1073 (1991) 437-441
53. Barry E.L., and Mosher D.F. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. The Journal of Biological Chemistry 264 (1989) 4179-4185
54. Brown L.F., Lanir N., McDonagh J., et al. Fibroblast migration in fibrin gel matrices. The American Journal of Pathology 142 (1993) 273-283
55. Blome M., Isgro F., Kiessling A.H., et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis 93 (2005) 1101-1107
56. Korte W., Truttmann B., Heim C., et al. Preoperative values of molecular coagulation markers identify patients at low risk for intra-operative haemostatic disorders and excessive blood loss. Clinical Chemistry and Laboratory Medicine 36 (1998) 235-240
57. Wettstein P., Haeberli A., Stutz M., et al. Decreased Factor XIII Availability for Thrombin and Early Loss of Clot Firmness in Patients with Unexplained Intra-operative Bleeding. Anesthesia and Analgesia 99 (2004) 1564-1569
58. Korte W., Gabi K., Rohner M., et al. Preoperative fibrin monomer measurement allows risk stratification for high intra-operative blood loss in elective surgery. Thrombosis and Haemostasis 94 (2005) 211-215
59. Noll T., Wozniak G., McCarson K., et al. Effect of factor XIII on endothelial barrier function. The Journal of Experimental Medicine 189 (1999) 1373-1382
60. Birnbaum J., Hein O.V., Luhrs C., et al. Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia. Critical Care 10 (2006) R29
61. Marzano A.V., Federici A.B., Gasparini G., et al. Coagulation factor XIII, endothelial damage and systemic sclerosis. European Journal of Dermatology 10 (2000) 14-17
62. Wozniak G., Noll T., Akinturk H., et al. Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Annals of the New York Academy of Sciences 936 (2001) 617-620
63. Nahrendorf M., Hu K., Frantz S., et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation 113 (2006) 1196-1202
64. Wozniak G., Noll T., Bott U., et al. Factor XIII: experimental and clinical results in diabetic foot ulcer. Zentralbl Chir 124 Suppl. 1 (1999) 73-77
65. Dardik R., Leor J., Skutelsky E., et al. Evaluation of the pro-angiogenic effect of factor XIII in heterotopic mouse heart allografts and FXIII-deficient mice. Thrombosis and Haemostasis 95 (2006) 546-550
66. Cario E., Goebell H., and Dignass A.U. Factor XIII modulates intestinal epithelial wound healing in vitro. Scandinavian Journal of Gastroenterology 34 (1999) 485-490
67. Zaets S.B., Xu D.Z., Lu Q., et al. Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury. Shock 31 (2009), Ga, Augusta 621-6